Chandan Healthcare Limited (NSE:CHANDAN)
India · Delayed Price · Currency is INR 227.10
-5.40 (-2.32%)
At close: Oct 1, 2026
Chandan Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 5,553 | 5,365 | 4,426 | - | - | - | |
Market Cap Growth | -1.69% | 21.21% | - | - | - | - |
Enterprise Value | 5,987 | 5,911 | 4,878 | - | - | - |
Last Close Price | 227.10 | 219.40 | 181.00 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 20.60 | 19.83 | 19.96 | - | - | - |
PS Ratio | 1.89 | 1.94 | 1.92 | - | - | - |
PB Ratio | 3.15 | 3.04 | 3.50 | - | - | - |
P/TBV Ratio | 3.33 | 3.22 | 3.75 | - | - | - |
P/OCF Ratio | 34.33 | 33.17 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.04 | 2.14 | 2.12 | - | - | - |
EV/EBITDA Ratio | 9.48 | 11.20 | 11.46 | - | - | - |
EV/EBIT Ratio | 11.39 | 13.75 | 13.61 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.31 | 0.31 | 0.38 | 0.82 | 0.72 | 0.63 |
Debt / EBITDA Ratio | 0.85 | 1.02 | 1.13 | 1.36 | 2.28 | 7.36 |
Net Debt / Equity Ratio | 0.22 | 0.22 | 0.21 | 0.70 | 0.55 | 0.57 |
Net Debt / EBITDA Ratio | 0.60 | 0.72 | 0.61 | 1.16 | 1.75 | 6.66 |
Net Debt / FCF Ratio | - | -1.44 | -0.63 | -1.66 | -21.04 | -27.68 |
Asset Turnover | - | 1.11 | 1.40 | 1.64 | 1.53 | 1.64 |
Inventory Turnover | - | 4.23 | 4.46 | 5.88 | 8.12 | 10.01 |
Quick Ratio | - | 1.32 | 1.22 | 0.59 | 0.52 | 0.68 |
Current Ratio | - | 2.13 | 1.94 | 1.06 | 0.95 | 0.96 |
Return on Equity (ROE) | - | 18.87% | 27.66% | 44.58% | 12.83% | -4.36% |
Return on Assets (ROA) | - | 10.74% | 13.61% | 13.36% | 5.09% | 0.25% |
Return on Invested Capital (ROIC) | 18.42% | 17.49% | 23.18% | 29.20% | 11.94% | 0.77% |
Return on Capital Employed (ROCE) | - | 20.30% | 23.30% | 38.30% | 17.70% | 0.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 5.18% | 5.04% | 5.01% | - | - | - |
FCF Yield | -4.75% | -4.92% | -9.37% | - | - | - |
Payout Ratio | - | - | 13.53% | 15.26% | - | - |
Buyback Yield / Dilution | -20.14% | -22.18% | -2.86% | - | - | - |
Total Shareholder Return | -20.14% | -22.18% | -2.86% | - | - | - |